Keenova Therapeutics plc Total Assets
Keenova Therapeutics plc had Total Assets of $5.21 billion as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-11
- 2026-06-30: Assets $5.21B.
- 2026-03-31: Assets $5.47B.
- 2025-12-31: Assets $5.63B.
- 2025-09-26: Assets $8.47B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $5.21B 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $5.47B 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $5.63B 10-Q · filed 2026-08-11 | |
| 2025-09-26 | $8.47B 10-Q · filed 2025-11-10 | |
| 2025-06-27 | $3.29B 10-Q · filed 2025-08-06 | |
| 2025-03-28 | $3.31B 10-Q · filed 2025-05-12 | |
| 2024-12-27 | $3.30B 10-K · filed 2026-04-15 | |
| 2024-09-27 | $3.64B 10-Q · filed 2024-11-05 | |
| 2024-06-28 | $3.57B 10-Q · filed 2024-08-06 | |
| 2024-03-29 | $3.63B 10-Q · filed 2024-05-09 | |
| 2023-12-29 | $3.73B 10-K · filed 2025-03-13 | |
| 2023-09-29 | $4.79B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $5.11B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.77B 10-Q · filed 2023-05-09 | |
| 2022-12-30 | $6.01B 10-K · filed 2024-03-26 | |
| 2022-09-30 | $6.26B 10-Q · filed 2022-11-08 | |
| 2022-07-01 | $6.49B 10-Q · filed 2022-08-11 | |
| 2022-04-01 | $8.70B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $8.92B 10-K · filed 2023-03-03 | |
| 2021-09-24 | $9.16B 10-Q · filed 2021-11-02 | |
| 2021-06-25 | $9.34B 10-Q · filed 2021-08-03 | |
| 2021-03-26 | $9.44B 10-Q · filed 2021-05-04 | |
| 2020-12-25 | $9.72B 10-K · filed 2022-03-15 | |
| 2020-09-25 | $9.70B 10-Q · filed 2020-11-03 | |
| 2020-06-26 | $9.69B 10-Q · filed 2020-08-04 | |
| 2020-03-27 | $10.17B 10-Q · filed 2020-05-06 | |
| 2019-12-27 | $10.34B 10-K · filed 2021-03-10 | |
| 2019-09-27 | $10.36B 10-Q · filed 2019-11-05 | |
| 2019-06-28 | $10.22B 10-Q · filed 2019-08-06 | |
| 2019-03-29 | $10.56B 10-Q · filed 2019-05-07 | |
| 2018-12-28 | $10.88B 10-K · filed 2020-02-26 | |
| 2018-09-28 | $14.91B 10-Q · filed 2018-11-06 | |
| 2018-06-29 | $15.05B 10-Q · filed 2018-08-07 | |
| 2018-03-30 | $15.52B 10-Q · filed 2018-05-08 | |
| 2017-12-29 | $15.28B 10-K · filed 2019-02-26 | |
| 2017-09-29 | $14.61B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $14.62B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $14.78B 10-Q · filed 2017-05-08 | |
| 2016-12-30 | $15.21B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $15.50B 10-QT · filed 2017-02-07 | |
| 2016-06-24 | $15.83B 10-Q · filed 2016-08-02 | |
| 2016-03-25 | $15.90B 10-Q · filed 2016-05-03 | |
| 2015-12-25 | $16.04B 10-Q · filed 2016-02-02 | |
| 2015-09-25 | $16.40B 10-K · filed 2016-11-29 | |
| 2015-06-26 | $14.88B 10-Q · filed 2015-08-04 | |
| 2015-03-27 | $12.81B 10-Q · filed 2015-05-05 | |
| 2014-12-26 | $12.77B 10-Q · filed 2015-02-03 | |
| 2014-09-26 | $12.79B 10-K · filed 2015-11-24 | $12.86B 10-K · filed 2014-11-25 |
| 2014-06-27 | $5.42B 10-Q · filed 2014-08-07 | |
| 2014-03-28 | $5.46B 10-Q · filed 2014-05-08 | |
| 2013-12-27 | $3.57B 10-Q · filed 2014-02-07 | |
| 2013-09-27 | $3.56B 8-K · filed 2015-04-03 | |
| 2013-06-28 | $3.31B 10-Q · filed 2013-08-12 | |
| 2012-09-28 | $2.90B 10-K · filed 2013-12-13 | $2.87B 10-Q · filed 2013-08-12 |